A study presented at the 3rd Congress of the European Academy of Neurology has found that medical cannabis might be useful in treating migraine headaches. The study was conducted by a team of Italian researchers led by Dr. Maria Nicolodi.
Phase 1 of the study found that oral doses of 200 milligrams of THC dropped acute pain by 55 percent, compared to doses of less than 100 milligrams which produced no relief.
During Phase 2, 79 patients who experienced chronic migraines were given a daily dose of either 25 milligrams of amitriptyline – an antidepressant often used to treat migraines – or 200 milligrams of a THC-CBD combination for a three-month period. Another group of patients who suffered from cluster headaches was also given the medical cannabis product or a 480 milligram dose of the calcium channel blocker verapamil. Patients still experiencing acute pain from either migraines or cluster headaches
... read more at: https://www.ganjapreneur.com/study-mmj-migraines/